Cardiovascular Disease and Kidney Transplantation
View More View Less
  • 1 Division of Nephrology and Transplantation, Maine Medical Center, and Tufts University School of Medicine, Portland, Maine
  • 2 Division of Renal Diseases and Hypertension, Transplant Center, University of Colorado Denver, Aurora, Colorado
  • 1.

    Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, : Trends in the causes of death among kidney transplant recipients in the United States (1996-2014). Am J Nephrol 48: 472481, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Lam NN, Kim SJ, Knoll GA, McArthur E, Lentine KL, Naylor KL, : The risk of cardiovascular disease is not increasing over time despite aging and higher comorbidity burden of kidney transplant recipients. Transplantation 101: 588596, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Lim WH, Johnson DW, Hawley CM, Pascoe E, Wong G: Impact of diabetes mellitus on the association of vascular disease before transplantation with long-term transplant and patient outcomes after kidney transplantation: A population cohort study. Am J Kidney Dis 71: 102111, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Ballesteros F, Allard J, Durand C, Cardinal H, Lalonde L, Fortin MC: Kidney transplant recipients’ perspectives on cardiovascular disease and related risk factors after transplantation: A qualitative study. Transplant Direct 3: e162, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Pihlstrøm HK, Mjøen G, Mucha S, Franke A, Jardine A, Fellström B, : Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients. Am J Transplant 19: 14441451, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Quaglia M, Musetti C, Merlotti G, Genazzani AA, Cargnin S, Cena T, : Pilot cohort study on the potential role of TCF7L2 rs7903146 on ischemic heart disease among non-diabetic kidney transplant recipients. Clin Transplant 31: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Molnar MZ, Nagy K, Remport A, Tapolyai MB, Fülöp T, Kamal F, : Inflammatory markers and outcomes in kidney transplant recipients. Transplantation 101: 21522164, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, ; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. Am J Transplant 5: 29292936, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Co MLF, Agdamag AC, Co MZ, Hertl M, Mohamedali B: Intensity-dependent benefit of statins in survival among prospective kidney transplant patients. Am J Cardiol 123: 254259, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Hartmann A: Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation. Clin Transplant 31: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Mourad G, Glyda M, Albano L, Viklický O, Merville P, Tydén G, : Incidence of post-transplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized, controlled Trial. Transplantation 101: 19241934, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, : Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. Cochrane Database Syst Rev 2: CD009966, 2017 PubMed

    • Search Google Scholar
    • Export Citation
  • 13.

    Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, : Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the folic acid for vascular outcome reduction in transplantation trial. Circulation 123: 17631770, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Merhi B, Shireman T, Carpenter MA, Kusek JW, Jacques P, Pfeffer M, : Serum phosphorus and risk of cardiovascular disease, all-cause mortality, or graft failure in kidney transplant recipients: An ancillary study of the FAVORIT trial cohort. Am J Kidney Dis 70: 377385, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Jeon HJ, Kim YC, Park S, Kim CT, Ha J, Han DJ, : Association of serum phosphorus concentration with mortality and graft failure among kidney transplant recipients. Clin J Am Soc Nephrol 12: 653662, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    van Londen M, Aarts BM, Deetman PE, van der Weijden J, Eisenga MF, Navis G, ; NIGRAM Consortium: Post-transplant hypophosphatemia and the risk of death-censored graft failure and mortality after kidney transplantation. Clin J Am Soc Nephrol 12: 13011310, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Weiner DE, Park M, Tighiouart H, Joseph AA, Carpenter MA, Goyal N, : Albuminuria and allograft failure, cardiovascular disease events, and all-cause death in stable kidney transplant recipients: A cohort analysis of the FAVORIT trial. Am J Kidney Dis 73: 5161, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Foster MC, Weiner DE, Bostom AG, Carpenter MA, Inker LA, Jarolim P, : Filtration markers, cardiovascular disease, mortality, and kidney outcomes in stable kidney transplant recipients: The FAVORIT trial. Am J Transplant 17: 23902399, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Park M, Katz R, Shlipak MG, Weiner D, Tracy R, Jotwani V, : Urinary markers of fibrosis and risk of cardiovascular events and death in kidney transplant recipients: The FAVORIT trial. Am J Transplant 17: 26402649, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Gill JS: Screening transplant waitlist candidates for coronary artery disease. Clin J Am Soc Nephrol 14: 112114, 2019 PubMed

  • 21.

    Paz Y, Morgenstern R, Weinberg R, Chiles M, Bhatti N, Ali Z, : Relation of coronary flow reserve to other findings on positron emission tomography myocardial perfusion imaging and left heart catheterization in patients with end-stage renal disease being evaluated for kidney transplant. Am J Cardiol 120: 19091912, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Chakkera HA, Angadi SS, Heilman RL, Kaplan B, Scott RL, Bollempalli H, : Cardiorespiratory fitness (peak oxygen uptake): Safe and effective measure for cardiovascular screening before kidney transplant. J Am Heart Assoc 7: e008662, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ: Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: A randomized crossover trial. Am J Kidney Dis 69: 796804, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 676 676 3
Full Text Views 409 409 35
PDF Downloads 254 254 16